OPEN Health Presenting Innovative Research on Capitalizing Data for Patient Access at ISPOR Europe
November 9, 2023 | Pharmanews, health, ispor
OPEN Health Presenting Innovative Research on Capitalizing Data for Patient Access at ISPOR Europe
London, UK – November 9, 2023 – OPEN Health, a preeminent global provider of consulting, HEOR and market access, patient engagement, and scientific and creative communications services, will be presenting innovative research at the upcoming ISPOR Europe conference in Copenhagen, Denmark. OPEN Health experts will contribute to the event through workshops, panel discussions, and 24 posters. Key themes of OPEN Health’s research presented this year are patient preference, advanced modeling methodologies, and HTA policy changes. The majority of OPEN Health’s Scientific Office will be onsite to discuss the role of HEOR science in shaping policy, including Dr. Elisabeth Fenwick, Chief Scientific Officer; Professor Ben van Hout, Scientific Founder; Dr. Marco Boeri, Director of Preference Research and scientific lead for Patient-Centered Outcomes; Emanuele Arcà, MSc, Senior Research Consultant in Strategic Market Access; and Maarten Treur, MSc, Vice President and Global Head of Modeling & Meta-Analysis.
Dr. Elisabeth Fenwick, Chief Scientific Officer at OPEN Health, said: “I am extremely proud to see the research we do at OPEN Health being presented by our scientific experts at the ISPOR EU conference in Copenhagen. The range of research topics covered this year shows the extent of our expertise in advanced techniques as well as key therapeutic areas.”
Dr. Marco Boeri, Director of Preference Research and scientific lead for Patient-Centered Outcomes at OPEN Health, said: “The importance of patient preference information is that it brings a systematic approach to implement the idea of patient-focused drug development promoted by the FDA, the EMA, and various HTA bodies around the world. Indeed, the patient voice is key to patient adherence, and by helping to understand unmet needs, it is key to the success of a pharmaceutical product.”
Emanuele Arcà, MSc, Senior Research Consultant in Strategic Market Access, said: “We are in a dynamic period of policy changes for access and HTA across regional, national, and international settings. HTA is taking a more prominent role in ensuring sustainable access to health innovations, while health innovations become exponentially more complex and expensive. We at OPEN Health are committed to understanding and shaping such changes through research and stakeholder engagement.”
OPEN Health will be presenting a virtual panel on November 10, ahead of ISPOR, on: “EU HTA Joint Clinical Assessments: Navigating Potential Challenges Ahead of 2025.” The panel is set to discuss several policy aspects regarding the current challenges and implications of the EU HTA regulation, covering topics such as the current position of EU HTA implementation, the major challenges expected across the industry, the stance of member states and various stakeholders, and strategies for the industry to prepare for joint clinical assessments. Register now to save your seat.
To learn more about our presence at ISPOR Europe, visit our website or meet the OPEN Health team at booth #C2-012 in Copenhagen.
About OPEN Health
OPEN Health unites deep scientific knowledge with wide-ranging specialist expertise to unlock possibilities that improve health outcomes and patient well-being. Working in partnership with our clients, we embrace our different perspectives and strengths to deliver fresh thinking and solutions that make a difference. OPEN Health is a flexible global organization that solves complex healthcare challenges across consulting, HEOR and market access, scientific communications, patient engagement, and creative omnichannel communications. For more information on OPEN Health, visit www.openhealthgroup.com.
Press contact:
OPEN Health
Candice Subero, Vice President, Global Marketing
This content was provided by OPEN Health
Company Details
Latest Content from OPEN Health
OPEN Health’s latest partnership with Rare Revolution Magazine
Richard Jones introduces our Head of Health Psychology (Dr Sumira Riaz)
OPEN Health CSR Report 2019
Margot Hannah, Partner and Group Managing Director, and CSR lead at OPEN Health shares her thoughts on our latest report.
OPEN Health at ECRD 2020
Gavin Jones shares his thoughts on why congress is so important at this time and the key sessions he is looking forward to.
OPEN Health discuss Global Community in Rare Disease
Annie Rankin how we can work smarter with healthcare professionals
OPEN Health Patient & Brand Communications highly commended finalist
Shortlisted for Best Patient-Centric Approach for 2020 BOBI Awards.
Succeeding with Star Wars Medicine
OPEN Health have published a new white paper demonstrating their commitment to leading the conversation on how effective healthcare communications, and tools that enable them, can lead to faster and...
Three steps I take for stress-free, successful virtual meetings and events
Stacey Osafo, Senior Account Manager, talks about some practical steps she uses for successful virtual meetings and events based on OPEN Health’s vast experience
OPEN Conversations – a webinar series with OPEN Health
OPEN Conversations is a webinar series where experts from OPEN Health answer your questions on pertinent topics in healthcare communications. Available live and on-demand, you can now catch up on...
COVID-19 message to clients from OPEN Health CEO, David Rowley
Dear OPEN Health Clients,I want to highlight to our clients what we’re doing in response to the Coronavirus outbreak to protect our staff, our clients and the community.We’re following the...
The field team are off the road! What should they do next?
Written by Briony Frost , OPEN Health